MedPath

Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT

Phase 4
Completed
Conditions
Living Donor Liver Transplantation
Interventions
Drug: Ascites replacement with albumin and hartmann's solution
Drug: Ascites replacement with hartmann's solution
Registration Number
NCT04184401
Lead Sponsor
Seoul National University Hospital
Brief Summary

The aim of this study is to evaluate difference in the rate of recovery of intestinal motility according to different ascites replacement strategy after living donor liver transplantation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • Adults (19 years or older)
  • Elective living donor liver transplantation
Exclusion Criteria
  • Previous abdominal surgery

  • Renal failure requiring renal replacement therapy

  • Contraindications for 5% albumin use

    1. Condition with potential risk caused by increased circulating plasma (heart failure, renal failure combined with oliguria, pulmonary edema)
    2. Hemolytic anemia
  • Contraindications for Hartmann solution

    1. Progressive lactic acidosis
    2. Hypervolemia
    3. Hypernatremia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Replacement with albuminAscites replacement with albumin and hartmann's solution1. Check drain amount every 4 hour after SICU admission 2. Replacement of 70% of drainage from previous 4 hours over next 4 hours * 30% of the drainage with 5% albumin * 40% of drainage with Hartmann's solution * If, serum K + level\> 5mEq/L, replace with 0.9% saline instead of Hartmann solution * If, serum albumin level is below 2.6 g/dL, inject 100mL of 20% albumin
Replacement with Hartmann's solutionAscites replacement with hartmann's solution1. Check drain amount every 4 hour after SICU admission 2. Replacement of 70% of drainage from previous 4 hours with Hartmann's solution over next 4 hours * If, serum K + level\> 5mEq/L, replace with 0.9% saline instead of Hartmann solution * If, serum albumin level is below 2.6 g/dL, inject 100mL of 20% albumin
Primary Outcome Measures
NameTimeMethod
Time to 1st flatuswithin 4 weeks

Interval between SICU admission and 1st flatus

Time to 1st dietwithin 4 weeks

Interval between SICU admission and 1st diet

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath